DMED

EURONEXT:DMED

Diagnamed Holdings Corp.

Stock

Last Close

0.01

25/09 14:21

Market Cap

1.60M

Beta: -

Volume Today

4.50K

Avg: 288.30K

PE Ratio

−2.85

PFCF: −3.95

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Sep '21	Sep '22	Sep '23
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses	481.90K -	572.83K 18.87%
selling general and administrative expenses	481.90K -	572.83K 18.87%	738.17K 28.86%
research and development expenses	201.77K -	562.86K 178.96%	514.75K 8.55%
other expenses
cost and expenses	683.67K -	1.14M 66.12%	1.25M 10.32%
operating expenses	683.67K -	1.14M 66.12%	1.25M 10.32%
interest expense
ebitda	580.48K -	-1.14M 296.21%	-1.25M 10.01%
operating income	580.48K -	-1.14M 296.21%	-1.25M 10.01%
depreciation and amortization
total other income expenses net	-1.26M -	3.26K 100.26%	-25.02K 867.57%
income before tax	-1.95M -	-1.13M 41.86%	-1.28M 12.85%
income tax expense
net income	-1.95M -	-1.13M 41.86%	-1.28M 12.85%
weighted average shs out	76.22M -	76.22M 0%	78.19M 2.59%
weighted average shs out dil	76.22M -	76.22M 0%	78.19M 2.59%
eps	-0.03 -	-0.01 41.80%	-0.02 9.40%
epsdiluted	-0.03 -	-0.01 41.80%	-0.02 9.40%

All numbers in (except ratios and percentages)